GUIDO J NEELS
CIK 1222362 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$143.97M
Companies
8
Total Filings
59
Lifetime Open-Market Net
-$21.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 125,000 | $0.92 | $114.4K | $52.6K | 6 | 2026-06-15 |
| TELA | Director | 11,925 | $0.67 | $8.0K | $0 | 1 | 2026-06-11 |
| BVS | Director | 117,523 | $13.21 | $1.55M | $0 | 10 | 2026-06-04 |
| AXGN | Director | 3,457,854 | $41.15 | $142.29M | -$22.68M | 20 | 2025-06-11 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 47,006 | — | — | $652.0K | 13 | 2019-04-03 |
| ENTELLUS MEDICAL INC (ENTL) Delisted | Director | 0 | — | — | $255.0K | 4 | 2018-03-01 |
| BIOPURE CORP (BPUR) Delisted | Director | 13,400 | — | — | $15.8K | 3 | 2008-09-16 |
| BIOPURE CORP (BPURD) Delisted | Director | 17,000 | — | — | $2.8K | 2 | 2007-07-19 |
Recent Filings · Page 2 of 6
59 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-04 | AXGN | Exer (M) | +11,904 | $0 | EDGAR |
| 2024-06-13 | BVS | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | BVS | Exer (M) | +30,400 | $0 | EDGAR |
| 2024-06-10 | AXGN | Grant (A) | +10,653 | $0 | EDGAR |
| 2023-09-07 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2023-08-18 | AXGN | Buy (P) | +10,000 | $61.1K | EDGAR |
| 2023-06-08 | BVS | Mixed | +16,648 | $0 | EDGAR |
| 2023-06-05 | AXGN | Exer (M) | +6,459 | $0 | EDGAR |
| 2022-06-22 | BVS | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | AXGN | Mixed | +3,036 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.